Home | UCSF Helen Diller Family Comprehensive Cancer Center

Shawn Hervey-Jumper, MD UCSF Neurosurgeon

Treat a Deadly Brain Tumor Before It Recurs? This AI Tool May Help

A new AI-based model can predict where the most common malignant brain cancer is most likely to return after initial surgery, potentially giving doctors a chance to treat it before it becomes visible on MRI.

Six Research Projects Funded Through UCSF Cancer Health Outcomes SPORE

From prostate and lung cancer to tumors of the central and peripheral nervous systems, scientists look to better assess cancer risk and tailor treatment decisions.

Kevan Shokat, PhD, looks at a digital image of a KRAS Q61h inhibitor with Julius Pampel, a graduate student in Shokat’s lab, at Genentech Hall on the UCSF Mission Bay Campus. Photo by Erin Lubin

UCSF’s Kevan Shokat Wins Stephenson Prize for Cancer Breakthrough

By finding a way to attack the most important human oncogene, KRAS, the UCSF chemical biologist launched a new era in cancer treatment.

2026 International Invasive Lobular Carcinoma Symposium

Here’s the Latest Research Lobular Breast Cancer Experts Are Leading

Invasive lobular carcinoma (ILC) is the second most common type of breast cancer but is challenging to detect because of how it spreads in breast tissue. Clinicians and researchers set to gather for the UCSF-cosponsored international invasive lobular carcinoma symposium in San Francisco, Sept. 23 to 25.

FDA Approves PET Imaging Agent for Brain Cancer Based on UCSF Data

UC San Francisco study data was instrumental in today’s approval by the Food and Drug Administration (FDA) of a PET imaging agent that helps physicians evaluate gliomas, a form of brain cancer.

Two daraxonrasib pills, which are blue and oval in shape.

New Drug With UCSF Roots Has Revolutionized Pancreatic Cancer Care

More than a decade after UCSF scientists discovered a way to target the once “undruggable” RAS protein, their work has led to an FDA-approved treatment that significantly extends survival for patients with metastatic pancreatic cancer.

Julian Hong, MD, stands outside at UCSF Mission Bay.

Shaping Our AI Future

Julian Hong, MD, discusses opportunities for AI in research and care, and why faculty and trainees will be essential to what comes next.

A pharmacy technician wearing blue latex glove and a surgical mask prepares a dose of the Moderna COVID-19 vaccine.

Why Novel Cancer Vaccine Tested at UCSF Marks New Treatment Era

A personalized mRNA vaccine tested at UC San Francisco has become the first to successfully prevent the return and spread of cancer in late-stage clinical trials. The results could signal a new era of vaccines to treat a range of cancers, says UCSF Professor of Medicine Adil Daud, MD, who led the university’s trial site.